ArticleProstate cancer and prostatic diseases2020

Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong's perspective.

Chi Leung Chiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.